Neurologic manifestations of HIV infection: Using imaging studies and antiviral therapy effectively

Postgraduate Medicine

Volumn 103, Issue 3, 1998, Pages 147-161

  Rachlis, Anita R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; GABAPENTIN; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; FUNGAL MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; LEUKOENCEPHALOPATHY; LYMPHOMA; MONONEUROPATHY MULTIPLEX; MYOPATHY; NEUROSYPHILIS; OPPORTUNISTIC INFECTION; POLYNEUROPATHY; POLYRADICULITIS; TOXOPLASMOSIS; TUBERCULOUS MENINGITIS;

EID: 0031887498     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.03.414     Document Type: Conference Paper

References (40)

1. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology 1994;44(10):1892-900
2. Centers for Disease Control and Prevention. Update: trends in AIDS incidence - United States, 1996. MMWR 1997;46(37):861-7
3. Gonda MA, Wong-Staal F, Gallo RC, et al. Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus. Science 1985;227(4683):173-7
4. Price RW. Neurological complications of HIV infection. Lancet 1996;348(9025):445-52
5. Ho DD, Rota TR, Schooley RT, et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985;313(24):1493-7
6. Gendelman HE, Persidsky Y, Ghorpade A, et al. The neuropathogenesis of the AIDS dementia complex. AIDS 1997;11 (Suppl A):35-45S
7. Working Group of the American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991;41(6):778-85
8. McArthur JC, Hoover DR, Bacellar H, et al, for the Multicenter AIDS Cohort Study Group. Dementia in AIDS patients: incidence and risk factors. Neurology 1993;43(11):2245-52
9. Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158(5):1079-83
10. Brew BJ, Miller J. Human immunodeficiency virus type 1-related transient neurological deficits. Am J Med 1996;101(3):257-61
11. Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19(6):517-24
12. Walot I, Miller BL, Chang L, et al. Neuroimaging findings in patients with AIDS. Clin Infect Dis 1996;22(6):906-19
13. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121(10):769-85 [Erratum, Ann Intern Med 1995;122(4):317]
14. Brew BJ, Pemberton L, Cunningham P, et al. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997;175(4):963-6
15. Gisslen M, Norkrans G, Svennerholm B, et al. The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine. J Infect Dis 1997;175(2):434-7
16. Portegies P, de Gans J, Lange JM, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 1989;299(6703):819-21 [Erratum, BMJ 1989;299(6708):1141]
17. Petito CK, Navia BA, Cho ES, et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312(14):874-9
18. Lipkin WI, Parry G, Kiprov D, et al. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology 1985; 35(10):1479-83
19. Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987;21(1):32-40
20. Freeman R, Roberts MS, Friedman LS, et al. Autonomic function and human immunodeficiency virus infection. Neurology 1990; 40(4):575-80
21. Becker K, Gorlach I, Frieling T, et al. Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS 1997;11(6):751-7
22. Simpson DM, Citak KA, Godfrey E, et al. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology 1993;43(5):971-6
23. Luft BJ, Hafner R, Korzun AH, et al, for the ACTG 077p/ANRS 009 Study Team. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1993; 329(14):995-1000
24. Vyas R, Ebright JR. Toxoplasmosis of the spinal cord in a patient with AIDS: case report and review. Clin Infect Dis 1996;23(5): 1061-5
25. Centers for Disease Control and Prevention. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1997;46(RR-12):1-46
26. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321(12):794-9
27. Darras-Joly C, Chevret S, Wolff M, et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis 1996;23(2):369-76
28. van der Horst CM, Saag MS, Cloud GA, et al, for the National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337(1):15-21
29. Larsen RA, Bozzette SA, Jones BE, et al. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1994;19(4):741-5
30. Berger JR, Kaszovitz B, Post MJ, et al. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987;107(1):78-87
31. Cinque P, Scarpellini P, Vago L, et al. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. (Editorial) AIDS 1997;11(1):1-17
32. Power C, Nath A, Aoki FY, et al. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. (Letter) N Engl J Med 1997;336(9):661-2
33. McCutchan JA. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis 1995;20(4):747-54
34. Arribas JR, Storch GA, Clifford DB, et al. Cytomegalovirus encephalitis. Ann Intern Med 1996;125(7):577-87
35. Cohen BA. Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS. Neurology 1996; 46(2):444-50
36. Tramont EC. Syphilis in adults: from Christopher Columbus to Sir Alexander Fleming to AIDS. Clin Infect Dis 1995;21(6):1361-9
37. Berenguer J, Moreno S, Laguna F, et al. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 1992;326(10):668-72
38. Farrar DJ, Flanigan TP, Gordon NM, et al. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med 1997;102(3):297-301
39. Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS 1994;8(8):1025-49
40. De Luca A, Antinori A, Cingolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995;90(4):844-9 [Erratum, Br J Haematol 1995;91(4): 1035]